Empirical Antibiotic Dosing for Acute Bacterial Meningitis
Initiate antibiotics within 1 hour of hospital presentation—never delay for lumbar puncture or imaging—and tailor the regimen by age and Listeria risk factors. 1, 2, 3
Critical Timing Principles
- Administer antibiotics within 60 minutes of arrival; delays beyond this threshold significantly increase mortality and neurological sequelae. 1, 2, 3
- Start treatment immediately on clinical suspicion—do not wait for CSF results, blood culture results, or CT imaging. 1, 2, 3
- Obtain blood cultures before the first antibiotic dose but never postpone treatment to do so. 1, 3
- If lumbar puncture is delayed (e.g., for CT in patients with focal deficits, new seizures, GCS <10, or severe immunocompromise), give antibiotics first. 1, 2
Empirical Regimens by Age and Risk Group
Neonates ≤4 Weeks
| Age | Regimen | Dosing |
|---|---|---|
| <1 week | Ampicillin + Cefotaxime ± Gentamicin | Ampicillin 50 mg/kg IV q8h; Cefotaxime 50 mg/kg IV q8h; Gentamicin 2.5 mg/kg IV q12h [1,2] |
| 1–4 weeks | Ampicillin + Cefotaxime ± Gentamicin | Ampicillin 50 mg/kg IV q6h; Cefotaxime 50 mg/kg IV q6–8h; Gentamicin 2.5 mg/kg IV q8h [1,2] |
- Rationale: Covers Group B Streptococcus, E. coli, and Listeria monocytogenes, the dominant neonatal pathogens. 1
- Alternative aminoglycosides: Tobramycin 2.5 mg/kg IV q8h or Amikacin 10 mg/kg IV q8h may substitute for gentamicin. 1
Children 1 Month–18 Years
Standard regimen:
Ceftriaxone 50 mg/kg IV q12h (maximum 2 g per dose) OR Cefotaxime 75 mg/kg IV q6–8h
PLUSVancomycin 10–15 mg/kg IV q6h (target trough 15–20 μg/mL) 1, 2, 4
Rationale: Provides coverage for S. pneumoniae (including penicillin- and cephalosporin-resistant strains), N. meningitidis, and H. influenzae. 1, 2, 4
Alternative to vancomycin: Rifampicin 10 mg/kg IV q12h (maximum 600 mg/day) in regions with low pneumococcal resistance. 1, 2
Adults 18–50 Years (Immunocompetent)
Standard regimen:
Ceftriaxone 2 g IV q12h (or 4 g IV q24h) OR Cefotaxime 2 g IV q4–6h
PLUSVancomycin 10–20 mg/kg IV q8–12h (target trough 15–20 μg/mL) 1, 2, 3
Rationale: Covers S. pneumoniae (including resistant strains) and N. meningitidis, the most common adult pathogens. 1, 2, 3
Alternative to vancomycin: Rifampicin 300 mg IV q12h in low-resistance settings. 1, 2
Adults >50 Years OR Immunocompromised (Any Age)
Standard regimen:
Ceftriaxone 2 g IV q12h (or 4 g IV q24h) OR Cefotaxime 2 g IV q4–6h
PLUSVancomycin 10–20 mg/kg IV q8–12h (target trough 15–20 μg/mL)
PLUSRationale: Adds Listeria monocytogenes coverage, which cephalosporins lack. 1, 2, 3
Listeria risk factors include: Age >50 years, diabetes mellitus, immunosuppressive therapy, malignancy, and other immunocompromising conditions. 1, 2, 3
Important caveat: In adults 18–50 years without risk factors, Listeria accounts for only 1.5% of cases, but adding ampicillin is reasonable if you wish to cover this rare possibility. 1
Adjunctive Dexamethasone
Dosing:
- Adults: Dexamethasone 10 mg IV q6h for 4 days 2, 5
- Children: Dexamethasone 0.15 mg/kg IV q6h for 2–4 days 4, 3
Timing:
- Administer with or 10–20 minutes before the first antibiotic dose; if not given initially, it can still be started up to 4 hours after antibiotics. 2, 5
Indications:
- Strongly recommended for suspected or proven pneumococcal or H. influenzae meningitis to reduce mortality and neurological sequelae (especially hearing loss). 2, 4, 5
- Discontinue dexamethasone if Listeria is identified, as observational data link adjunctive steroids to increased mortality in neurolisteriosis. 2
- For N. meningitidis, there is no clear harm or benefit; the decision to continue or stop can be individualized. 2
Treatment Duration by Pathogen
| Pathogen | Duration |
|---|---|
| N. meningitidis | 5–7 days [3] |
| S. pneumoniae | 10–14 days [3] |
| H. influenzae | 10 days [3,6] |
| L. monocytogenes | 21 days [3,7] |
| Culture-negative (clinically recovered) | 10 days [3] |
- Do not stop antibiotics prematurely based solely on clinical improvement; complete the pathogen-specific duration to prevent relapse. 3
Common Pitfalls to Avoid
- Never delay antibiotics for imaging. If CT is indicated (focal deficits, new seizures, GCS <10, severe immunocompromise), give antibiotics first, then obtain the scan. 1, 2, 3
- Never omit ampicillin in patients >50 years or immunocompromised; cephalosporins have no activity against Listeria, and omission can be fatal. 1, 2, 3
- Never underdose. Meningitis requires high-dose therapy to achieve adequate CSF penetration; standard dosing may lead to treatment failure. 3
- Never fail to obtain blood cultures before antibiotics, but do not delay treatment beyond 1 hour to do so. 1, 3
- Never ignore local resistance patterns, especially after recent travel to areas with high pneumococcal resistance; add vancomycin or rifampicin to the third-generation cephalosporin in these settings. 1, 2, 3
Regional Resistance Considerations
- In regions with high pneumococcal penicillin or cephalosporin resistance, add vancomycin or rifampicin to ceftriaxone/cefotaxime. 1, 2, 3
- When true cephalosporin resistance (MIC >2 mg/L) is unlikely, some experts suggest ceftriaxone/cefotaxime alone, but adding vancomycin is recommended as a safety measure. 1, 3